Global Peripheral Intervention Drug-Eluting Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Global Peripheral Intervention Drug-Eluting Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Peripheral Intervention Drug-Eluting Devices Introduction
1.2 Market Analysis by Type
1.2.1 Plain Old Balloon Angioplasty (POBA)
1.2.2 Percutaneous Transluminal Angioplasty (PTA)
1.3 Market Analysis by Applications
1.3.1 Drug-Eluting Balloons
1.3.2 Drug-Eluting Stents
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic plc
2.1.1 Business Overview
2.1.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boston Scientific Corporation
2.2.1 Business Overview
2.2.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott Laboratories
2.3.1 Business Overview
2.3.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cardinal Health
2.4.1 Business Overview
2.4.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 B. Braun Melsungen AG
2.5.1 Business Overview
2.5.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biosensors International Group Ltd.
2.6.1 Business Overview
2.6.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 C.R. Bard, Inc.
2.7.1 Business Overview
2.7.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 St. Jude Medical, Inc.
2.8.1 Business Overview
2.8.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 The Lubrizol Corporation
2.9.1 Business Overview
2.9.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Terumo Corporation
2.10.1 Business Overview
2.10.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Peripheral Intervention Drug-Eluting Devices Market Analysis by Regions
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.3 Europe Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.5 South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
5 North America Peripheral Intervention Drug-Eluting Devices by Countries
5.1 North America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
5.3 Canada Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6 Europe Peripheral Intervention Drug-Eluting Devices by Countries
6.1 Europe Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.3 UK Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.4 France Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.5 Russia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.6 Italy Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Peripheral Intervention Drug-Eluting Devices by Countries
7.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.3 Japan Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.4 Korea Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.5 India Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
8 South America Peripheral Intervention Drug-Eluting Devices by Countries
8.1 South America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Peripheral Intervention Drug-Eluting Devices by Countries
9.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.3 UAE Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
10 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Type
10.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2013-2018)
10.2 Plain Old Balloon Angioplasty (POBA) Sales Growth and Price
10.2.1 Global Plain Old Balloon Angioplasty (POBA) Sales Growth (2013-2018)
10.2.2 Global Plain Old Balloon Angioplasty (POBA) Price (2013-2018)
10.3 Percutaneous Transluminal Angioplasty (PTA) Sales Growth and Price
10.3.1 Global Percutaneous Transluminal Angioplasty (PTA) Sales Growth (2013-2018)
10.3.2 Global Percutaneous Transluminal Angioplasty (PTA) Price (2013-2018)
11 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Application
11.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2013-2018)
11.2 Drug-Eluting Balloons Sales Growth (2013-2018)
11.3 Drug-Eluting Stents Sales Growth (2013-2018)
12 Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Peripheral Intervention Drug-Eluting Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.2 Europe Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.4 South America Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.3 Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2018-2023)
12.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Type (2018-2023)
12.4 Peripheral Intervention Drug-Eluting Devices Market Forecast by Application (2018-2023)
12.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Peripheral Intervention Drug-Eluting Devices Picture
Table Product Specifications of Peripheral Intervention Drug-Eluting Devices
Figure Global Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Types in 2017
Table Peripheral Intervention Drug-Eluting Devices Types for Major Manufacturers
Figure Plain Old Balloon Angioplasty (POBA) Picture
Figure Percutaneous Transluminal Angioplasty (PTA) Picture
Figure Peripheral Intervention Drug-Eluting Devices Sales Market Share by Applications in 2017
Figure Drug-Eluting Balloons Picture
Figure Drug-Eluting Stents Picture
Figure United States Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure France Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure UK Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure China Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure India Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Table Medtronic plc Basic Information, Manufacturing Base and Competitors
Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cardinal Health Basic Information, Manufacturing Base and Competitors
Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Type and Applications
Table B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biosensors International Group Ltd. Basic Information, Manufacturing Base and Competitors
Table Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C.R. Bard, Inc. Basic Information, Manufacturing Base and Competitors
Table C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Type and Applications
Table C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table St. Jude Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Type and Applications
Table St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table The Lubrizol Corporation Basic Information, Manufacturing Base and Competitors
Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Type and Applications
Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer (2016-2017)
Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturer in 2016
Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturer in 2017
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2016-2017)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2016
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2017
Figure Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2017
Figure Global Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Regions (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Regions (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Regions (2013-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2013
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2017
Figure North America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table North America Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Figure North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2013
Figure North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2017
Table North America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Table North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2013-2018)
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2013
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017
Figure United States Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Canada Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Table Europe Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2016
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017
Figure Germany Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure UK Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure France Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Russia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Italy Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries 2017
Table Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries 2017
Figure China Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Japan Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Korea Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure India Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure South America Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table South America Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Figure South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2017
Table South America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Table South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2013-2018)
Figure South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017
Figure Brazil Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Argentina Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Colombia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2017
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2013
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017
Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure UAE Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Nigeria Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2013-2018)
Figure Global Plain Old Balloon Angioplasty (POBA) Sales Growth (2013-2018)
Figure Global Plain Old Balloon Angioplasty (POBA) Price (2013-2018)
Figure Global Percutaneous Transluminal Angioplasty (PTA) Sales Growth (2013-2018)
Figure Global Percutaneous Transluminal Angioplasty (PTA) Price (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2013-2018)
Figure Global Drug-Eluting Stents Sales Growth (2013-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Growth Rate (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Regions (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Regions (2018-2023)
Figure North America Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Figure Europe Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Figure Asia-Pacific Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Figure South America Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Figure Middle East and Africa Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Type (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs